Exercise 2-20 (Algo) Worksheet [Appendix 2A] [The following information applies to the questions displayed below.] The December 31, 2024, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. The following year-end adjusting entries are required: a. Depreciation expense for the year on the equipment is $8,600. b. Salaries at year-end should be accrued in the amount of $5,480